Invention Grant
- Patent Title: Agent for overcoming immunosuppression and use thereof
-
Application No.: US16073871Application Date: 2017-02-15
-
Publication No.: US11213538B2Publication Date: 2022-01-04
- Inventor: Akira Asai , Naohisa Ogo , Daisuke Muraoka , Hiroshi Shiku , Naozumi Harada
- Applicant: GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION , KABUSHIKI KAISHA YAKULT HONSHA
- Applicant Address: JP Mishima; JP Minato-ku
- Assignee: GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION,KABUSHIKI KAISHA YAKULT HONSHA
- Current Assignee: GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION,KABUSHIKI KAISHA YAKULT HONSHA
- Current Assignee Address: JP Mishima; JP Minato-ku
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JPJP2016-026745 20160216
- International Application: PCT/JP2017/005566 WO 20170215
- International Announcement: WO2017/141981 WO 20170824
- Main IPC: A61K31/704
- IPC: A61K31/704 ; A61K35/17 ; A61P35/00 ; A61P37/02 ; A61K45/00 ; A61K39/00 ; A61K45/06
Abstract:
To provide an agent for overcoming immunosuppression which can overcome immunosuppression by regulatory T cells. An agent for overcoming immunosuppression and an inhibitor of FOXP3 function containing an anthracycline antibiotic as an active ingredient.
Public/Granted literature
- US20190038645A1 AGENT FOR OVERCOMING IMMUNOSUPPRESSION AND USE THEREOF Public/Granted day:2019-02-07
Information query
IPC分类:
